Bill > SB119

This bill aims to improve the Medicaid pharmaceutical services in New Hampshire by modifying existing laws to allow for more flexible and cost-effective medication dispensing. The bill directs pharmacists to dispense brand name drugs to Medicaid beneficiaries when those drugs are on the department of health and human services' preferred drug list, even if generic alternatives are available. Additionally, the bill allows the department's chief medical officer to create standing orders for certain over-the-counter medications, medical supplies, and laboratory tests when they are deemed medically necessary and cost-effective. The legislation is designed to optimize the state's Medicaid pharmacy program by potentially lowering net drug costs through manufacturer rebate agreements, with the department's actuaries estimating net savings of $1.1 million in fiscal year 2026, increasing to $4.5 million by fiscal year 2028. The bill also provides legal protection for healthcare professionals who issue or distribute items through these standing orders, ensuring they cannot be held liable when acting in good faith and with reasonable care. The changes are intended to improve access to pharmaceutical products, streamline prescribing processes, and create a more standardized approach to drug coverage in the Medicaid program.

Health and Social Services

https://gc.nh.gov/bill_status/legacy/bs2016/bill_docket.aspx?lsr=362&sy=2025&sortoption=&txtsessionyear=2025&txtbillnumber=SB119